LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 80.31 | 27.76 | 11371 | 6976 | 1.6300 | 1.1264 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 82.01 | 27.76 | 560 | 7000 | 0.0800 | 0.4573 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 82.01 | 27.76 | 12087 | 7000 | 1.7266 | 1.1417 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 82.01 | 27.76 | 1284 | 7000 | 0.1834 | 0.6170 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 82.01 | 27.76 | 11603 | 7000 | 1.6575 | 1.1308 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 83.72 | 27.76 | 632 | 7055 | 0.0896 | 0.4787 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 83.72 | 27.76 | 12244 | 7055 | 1.7353 | 1.1429 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 83.72 | 27.76 | 1240 | 7055 | 0.1758 | 0.6089 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 83.72 | 27.76 | 11817 | 7055 | 1.6748 | 1.1334 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 85.42 | 27.76 | 646 | 7025 | 0.0919 | 0.4832 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 85.42 | 27.76 | 12517 | 7025 | 1.7816 | 1.1500 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 85.42 | 27.76 | 1203 | 7025 | 0.1712 | 0.6034 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 85.42 | 27.76 | 12105 | 7025 | 1.7230 | 1.1410 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 87.13 | 27.76 | 669 | 6987 | 0.0957 | 0.4903 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 87.13 | 27.76 | 12838 | 6987 | 1.8372 | 1.1585 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 87.13 | 27.76 | 1287 | 6987 | 0.1842 | 0.6177 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 87.13 | 27.76 | 12352 | 6987 | 1.7676 | 1.1481 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 88.84 | 27.76 | 656 | 6965 | 0.0942 | 0.4870 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 88.84 | 27.76 | 12909 | 6965 | 1.8534 | 1.1610 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 88.84 | 27.76 | 1197 | 6965 | 0.1719 | 0.6035 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 88.84 | 27.76 | 12619 | 6965 | 1.8118 | 1.1548 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 90.55 | 27.76 | 613 | 6928 | 0.0885 | 0.4750 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 90.55 | 27.76 | 13228 | 6928 | 1.9092 | 1.1692 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 90.55 | 27.76 | 1011 | 6928 | 0.1459 | 0.5706 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 90.55 | 27.76 | 12861 | 6928 | 1.8562 | 1.1615 | MN20160318_Q01 | M19 |